HCA Healthcare, Inc. (HCA) EBITDA
- 2026-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $930.00M.
- 2025-09-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $889.00M.
- 2025-06-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $863.00M.
- 2025-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $860.00M.
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | (m) | $930.00M | (m) | (m) | $1.12B | $2.01B | (m) | (m) | (m) | $430.00M |
| 2025-09-30 | Reported | (m) | (m) | $889.00M | (m) | (m) | $1.29B* | $4.42B* | (m) | (m) | (m) | $515.00M |
| 2025-06-30 | Reported | (m) | (m) | $863.00M | (m) | (m) | $1.18B* | $4.21B* | (m) | (m) | (m) | $524.00M |
| 2025-03-31 | Reported | (m) | (m) | $860.00M | (m) | (m) | $991.00M | $1.65B | (m) | (m) | (m) | $502.00M |
| 2024-09-30 | Reported | (m) | (m) | $842.00M | (m) | (m) | $1.19B* | $3.52B* | (m) | (m) | (m) | $424.00M |
| 2024-06-30 | Reported | (m) | (m) | $819.00M | (m) | (m) | $1.28B* | $1.97B* | (m) | (m) | (m) | $550.00M |
| 2024-03-31 | Reported | (m) | (m) | $795.00M | (m) | (m) | $1.12B | $2.47B | (m) | (m) | (m) | $445.00M |
| 2023-09-30 | Reported | (m) | (m) | $769.00M | (m) | (m) | $1.15B* | $2.48B* | (m) | (m) | (m) | $355.00M |
| 2023-06-30 | Reported | (m) | (m) | $763.00M | (m) | (m) | $1.24B* | $2.48B* | (m) | (m) | (m) | $397.00M |
| 2023-03-31 | Reported | (m) | (m) | $756.00M | (m) | (m) | $1.20B | $1.80B | (m) | (m) | (m) | $379.00M |
| 2022-09-30 | Reported | (m) | (m) | $749.00M | (m) | (m) | $1.13B* | $3.02B* | (m) | (m) | (m) | $360.00M |
| 2022-06-30 | Reported | (m) | (m) | $738.00M | (m) | (m) | $1.08B* | $1.63B* | (m) | (m) | (m) | $381.00M |
| 2022-03-31 | Reported | (m) | (m) | $732.00M | (m) | (m) | $861.00M | $1.34B | (m) | (m) | (m) | $349.00M |
| 2021-09-30 | Reported | (m) | (m) | $716.00M | (m) | (m) | $889.00M* | $2.28B* | (m) | (m) | (m) | $685.00M |
| 2021-06-30 | Reported | (m) | (m) | $712.00M | (m) | (m) | $842.00M* | $2.25B* | (m) | (m) | (m) | $453.00M |
| 2021-03-31 | Reported | (m) | (m) | $697.00M | (m) | (m) | $654.00M | $1.99B | (m) | (m) | (m) | $393.00M |
| 2020-09-30 | Reported | (m) | (m) | $694.00M | (m) | (m) | $489.00M* | $2.72B* | (m) | (m) | (m) | $209.00M |
| 2020-06-30 | Reported | (m) | (m) | $691.00M | (m) | (m) | $745.00M* | $8.72B* | (m) | (m) | (m) | $344.00M |
| 2020-03-31 | Reported | (m) | (m) | $674.00M | (m) | (m) | $853.00M | $1.38B | (m) | (m) | (m) | $112.00M |
| 2019-09-30 | Reported | (m) | (m) | $647.00M | (m) | (m) | $1.14B* | $2.13B* | (m) | (m) | (m) | $215.00M |
| 2019-06-30 | Reported | (m) | (m) | $636.00M | (m) | (m) | $964.00M* | $2.00B* | (m) | (m) | (m) | $271.00M |
| 2019-03-31 | Reported | (m) | (m) | $619.00M | (m) | (m) | $781.00M | $974.00M | (m) | (m) | (m) | $279.00M |
| 2018-09-30 | Reported | (m) | (m) | $582.00M | (m) | (m) | $846.00M* | $1.72B* | (m) | (m) | (m) | $173.00M |
| 2018-06-30 | Reported | (m) | (m) | $562.00M | (m) | (m) | $880.00M* | $1.58B* | (m) | (m) | (m) | $272.00M |
| 2018-03-31 | Reported | (m) | (m) | $553.00M | (m) | (m) | $694.00M | $1.28B | (m) | (m) | (m) | $257.00M |
| 2017-09-30 | Reported | (m) | (m) | $539.00M | (m) | (m) | $729.00M* | $1.01B* | (m) | (m) | (m) | $248.00M |
| 2017-06-30 | Reported | (m) | (m) | $521.00M | (m) | (m) | $733.00M* | (m) | (m) | (m) | (m) | $365.00M |
| 2017-03-31 | Reported | (m) | (m) | $521.00M | (m) | (m) | $571.00M | (m) | (m) | (m) | (m) | $289.00M |
| 2016-09-30 | Reported | (m) | (m) | $495.00M | (m) | (m) | $712.00M* | (m) | (m) | (m) | (m) | $273.00M |
| 2016-06-30 | Reported | (m) | (m) | $489.00M | (m) | (m) | $663.00M* | (m) | (m) | (m) | (m) | $341.00M |
| 2016-03-31 | Reported | (m) | (m) | $479.00M | (m) | (m) | $509.00M | (m) | (m) | (m) | (m) | $284.00M |
| 2015-09-30 | Reported | (m) | (m) | $482.00M | (m) | (m) | $567.00M* | (m) | (m) | (m) | (m) | $270.00M |
| 2015-06-30 | Reported | (m) | (m) | $469.00M | (m) | (m) | $558.00M* | (m) | (m) | (m) | (m) | $319.00M |
| 2015-03-31 | Reported | (m) | (m) | $473.00M | (m) | (m) | $446.00M | (m) | (m) | (m) | (m) | $358.00M |
| 2014-09-30 | Reported | (m) | (m) | $460.00M | (m) | (m) | $569.00M* | (m) | (m) | (m) | (m) | $318.00M |
| 2014-06-30 | Reported | (m) | (m) | $454.00M | (m) | (m) | $513.00M* | (m) | (m) | (m) | (m) | $272.00M |
| 2014-03-31 | Reported | (m) | (m) | $447.00M | (m) | (m) | $400.00M | (m) | (m) | (m) | (m) | $226.00M |
| 2013-09-30 | Reported | (m) | (m) | $443.00M | (m) | (m) | $451.00M* | $900.00M* | (m) | (m) | (m) | $234.00M |
| 2013-06-30 | Reported | (m) | (m) | $425.00M | (m) | (m) | $492.00M* | $814.00M* | (m) | (m) | (m) | $269.00M |
| 2013-03-31 | Reported | (m) | (m) | $424.00M | (m) | (m) | $404.00M | $740.00M | (m) | (m) | (m) | $201.00M |
| 2012-09-30 | Reported | (m) | (m) | $417.00M | (m) | (m) | $484.00M* | $655.00M* | (m) | (m) | (m) | $222.00M |
| 2012-06-30 | Reported | (m) | (m) | $420.00M | (m) | (m) | $449.00M* | $1.46B* | (m) | (m) | (m) | $214.00M |
| 2012-03-31 | Reported | (m) | (m) | $417.00M | (m) | (m) | $335.00M | $797.00M | (m) | (m) | (m) | $324.00M |
| 2011-09-30 | Reported | (m) | (m) | $362.00M | (m) | (m) | $394.00M* | $880.00M* | (m) | (m) | (m) | -$23.00M |
| 2011-06-30 | Reported | (m) | (m) | $358.00M | (m) | (m) | $447.00M* | $748.00M* | (m) | (m) | (m) | $147.00M |
| 2011-03-31 | Reported | (m) | (m) | $358.00M | (m) | (m) | $329.00M | $918.00M | (m) | (m) | (m) | $183.00M |
| 2010-09-30 | Reported | (m) | (m) | $352.00M | (m) | (m) | $324.00M* | $1.26B* | (m) | (m) | (m) | $143.00M |
| 2010-06-30 | Reported | (m) | (m) | $355.00M | (m) | (m) | $322.00M* | $436.00M* | (m) | (m) | (m) | $136.00M |
| 2010-03-31 | Reported | (m) | (m) | $355.00M | (m) | (m) | $214.00M | $859.00M | (m) | (m) | (m) | $209.00M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | (m) | $3.52B | (m) | (m) | $4.94B | $12.64B | (m) | (m) | (m) | $2.05B |
| 2024-12-31 | Reported | (m) | (m) | $3.31B | (m) | (m) | $4.88B | $10.51B | (m) | (m) | (m) | $1.87B |
| 2023-12-31 | Reported | (m) | (m) | $3.08B | (m) | (m) | $4.74B | $9.43B | (m) | (m) | (m) | $1.61B |
| 2022-12-31 | Reported | (m) | (m) | $2.97B | (m) | (m) | $4.39B | $8.52B | (m) | (m) | (m) | $1.75B |
| 2021-12-31 | Reported | (m) | (m) | $2.85B | (m) | (m) | $3.58B | $8.96B | (m) | (m) | (m) | $2.11B |
| 2020-12-31 | Reported | (m) | (m) | $2.72B | (m) | (m) | $2.83B | $9.23B | (m) | (m) | (m) | $1.04B |
| 2019-12-31 | Reported | (m) | (m) | $2.60B | (m) | (m) | $4.16B | $7.60B | (m) | (m) | (m) | $1.10B |
| 2018-12-31 | Reported | (m) | (m) | $2.28B | (m) | (m) | $3.57B | $6.76B | (m) | (m) | (m) | $946.00M |
| 2017-12-31 | Reported | (m) | (m) | $2.13B | (m) | (m) | $3.02B | $5.43B | (m) | (m) | (m) | $1.64B |
| 2016-12-31 | Reported | (m) | (m) | $1.97B | (m) | (m) | $2.76B | $5.65B | (m) | (m) | (m) | $1.38B |
| 2015-12-31 | Reported | (m) | (m) | $1.90B | (m) | (m) | $2.38B | (m) | (m) | (m) | (m) | $1.26B |
| 2014-12-31 | Reported | (m) | (m) | $1.82B | (m) | (m) | $2.18B | $4.45B | (m) | (m) | (m) | $1.11B |
| 2013-12-31 | Reported | (m) | (m) | $1.75B | (m) | (m) | $1.94B | $3.68B | (m) | (m) | (m) | $950.00M |
| 2012-12-31 | Reported | (m) | (m) | $1.68B | (m) | (m) | $1.86B | $4.17B | (m) | (m) | (m) | $888.00M |
| 2011-12-31 | Reported | (m) | (m) | $1.47B | (m) | (m) | $1.68B | $3.93B | (m) | (m) | (m) | $719.00M |
| 2010-12-31 | Reported | (m) | (m) | $1.42B | (m) | (m) | $1.32B | $3.08B | (m) | (m) | (m) | $658.00M |
| 2009-12-31 | Reported | (m) | (m) | $1.43B | (m) | (m) | $1.32B | $2.75B | (m) | (m) | (m) | $627.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |